Ainos Inc

-0.04 (-5.86%)
Products, Regulatory

Ainos Publishes Preclinical Data On VELDONA Formulation's Potential

Published: 11/21/2022 11:47 GMT
Ainos Inc (AIMD) - Ainos Publishes Preclinical Data Demonstrating Its Veldona Formulation's Potential As Treatment Candidates for the Most Common Medical Conditions for Companion Animals.
Ainos Inc - Advances Its Product Pipeline As It Targets Commencing Clinical Studies During Q2 of 2023.
Ainos Inc - Intends to Begin Clinical Studies to Assess Veldona's Potential Use in Treatment of Fcgs and Canine Atopic Dermatitis During Q2 of 2023.
Ainos Inc - Based on Veldona's Effective Antiviral Efficacy, Co is Planning an Expansion of Its Use for Treatment of Humans to Treatment of Animals.